Mark Rosenblum

A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting

E. Antonio Chiocca, Khalid M. Abbed, Stephen B. Tatter et al. · Molecular Therapy · 2004 · 440 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas

Aiguo Li, Jennifer Walling, Yuri Kotliarov et al. · Molecular Cancer Research · 2008 · 260 citations · Full text

Life Sciences, Genetics, Oncology +13

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.

Warren Mason, Alfred Grovas, Samantha E. Halpern et al. · Journal of Clinical Oncology · 1998 · 239 citations

Medicine, Oncology, Chemotherapy +15

The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial

Ali Ziada, Albaha Barqawi, L. Michael Glode et al. · The Prostate · 2004 · 182 citations

Medicine, Oncology, Pharmacology +15

High-resolution Global Genomic Survey of 178 Gliomas Reveals Novel Regions of Copy Number Alteration and Allelic Imbalances

Yuri Kotliarov, Mary Ellen Steed, Neil Christopher et al. · Cancer Research · 2006 · 129 citations · Full text

Medicine, Genetics, Oncology +17